58 related articles for article (PubMed ID: 34263002)
1. Large-scale quantitative glycoproteomics analysis of site-specific glycosylation occupancy.
Pan S; Tamura Y; Chen R; May D; McIntosh MW; Brentnall TA
Mol Biosyst; 2012 Nov; 8(11):2850-6. PubMed ID: 22892896
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in mass spectrometry (MS)-based glycoproteomics in complex biological samples.
Chen Z; Huang J; Li L
Trends Analyt Chem; 2019 Sep; 118():880-892. PubMed ID: 31579312
[TBL] [Abstract][Full Text] [Related]
3. Human brain glycoform co-regulation network and glycan modification alterations in Alzheimer's disease.
Zhang Q; Ma C; Chin LS; Pan S; Li L
bioRxiv; 2023 Nov; ():. PubMed ID: 38014218
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery.
Zhang Y; Jiao J; Yang P; Lu H
Clin Proteomics; 2014; 11(1):18. PubMed ID: 24872809
[TBL] [Abstract][Full Text] [Related]
5.
Sun S; Hu Y; Ao M; Shah P; Chen J; Yang W; Jia X; Tian Y; Thomas S; Zhang H
Clin Proteomics; 2019; 16():35. PubMed ID: 31516400
[TBL] [Abstract][Full Text] [Related]
6. Integrated Systems Analysis Deciphers Transcriptome and Glycoproteome Links in Alzheimer's Disease.
Matsui Y; Togayachi A; Sakamoto K; Angata K; Kadomatsu K; Nishihara S
bioRxiv; 2024 May; ():. PubMed ID: 38234803
[TBL] [Abstract][Full Text] [Related]
7. Large-Scale Measurement of Absolute Protein Glycosylation Stoichiometry.
Sun S; Zhang H
Anal Chem; 2015 Jul; 87(13):6479-82. PubMed ID: 26066578
[TBL] [Abstract][Full Text] [Related]
8. Human brain glycoform coregulation network and glycan modification alterations in Alzheimer's disease.
Zhang Q; Ma C; Chin LS; Pan S; Li L
Sci Adv; 2024 Apr; 10(14):eadk6911. PubMed ID: 38579000
[TBL] [Abstract][Full Text] [Related]
9. Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome.
Thaysen-Andersen M; Packer NH
Biochim Biophys Acta; 2014 Sep; 1844(9):1437-52. PubMed ID: 24830338
[TBL] [Abstract][Full Text] [Related]
10. Towards structure-focused glycoproteomics.
Chernykh A; Kawahara R; Thaysen-Andersen M
Biochem Soc Trans; 2021 Feb; 49(1):161-186. PubMed ID: 33439247
[TBL] [Abstract][Full Text] [Related]
11. Differential Analysis of N-glycopeptide Abundance and N-glycosylation Site Occupancy for Studying Protein N-glycosylation Dysregulation in Human Disease.
Zhang Q; Ma C; Li L; Chin LS
Bio Protoc; 2021 Jun; 11(12):e4059. PubMed ID: 34263002
[TBL] [Abstract][Full Text] [Related]
12. Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer's disease.
Zhang Q; Ma C; Chin LS; Li L
Sci Adv; 2020 Oct; 6(40):. PubMed ID: 33008897
[TBL] [Abstract][Full Text] [Related]
13. Systems analysis of singly and multiply O-glycosylated peptides in the human serum glycoproteome via EThcD and HCD mass spectrometry.
Zhang Y; Xie X; Zhao X; Tian F; Lv J; Ying W; Qian X
J Proteomics; 2018 Jan; 170():14-27. PubMed ID: 28970103
[TBL] [Abstract][Full Text] [Related]
14. In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease.
Chen Z; Yu Q; Yu Q; Johnson J; Shipman R; Zhong X; Huang J; Asthana S; Carlsson C; Okonkwo O; Li L
Mol Cell Proteomics; 2021; 20():100081. PubMed ID: 33862227
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
